27th Jun 2025 12:27
27 June 2025
Cambridge Cognition Holdings plc
("Cambridge Cognition", the "Company" or the "Group")
Result of AGM
Cambridge Cognition Holdings plc, the brain health software group specialising in digital health products that advance brain health research and treatment, held its Annual General Meeting ("AGM") earlier today at the registered office of the Company; Tunbridge Court, Tunbridge Lane, Bottisham, Cambridge, CB25 9TU and announces that all resolutions put forward were duly passed.
Proxy votes were received in respect of 67.6% of the Company's issued share capital. The votes cast were as follows:
| Resolution | Votes For | Percent of votes cast For | Votes Against | Percent of votes cast Against | Votes Withheld |
1 | To approve the 2024 Report and Accounts | 28,372,450 | 100% | - | - | - |
2 | To approve the 2024 Directors' Remuneration Report1 | 28,346,127 | 99.91% | 25,315 | 0.09% | 1,008 |
3 | To approve the Directors' Remuneration Policy1 | 28,346,127 | 99.91% | 25,315 | 0.09% | 1,008 |
4 | To re-appoint the auditors | 28,359,763 | 99.99% | 3,500 | 0.01% | 9,187 |
5 | To authorise the directors to set the auditors' remuneration | 28,370,475 | 100% | - | - | 1,975 |
6 | To re-elect Steven Powell as a director | 28,369,043 | 100% | - | - | 3,407 |
7 | To re-elect Richard Bungay as a director | 24,074,907 | 100% | - | - | 4,297,543 |
8 | To re-elect Stuart Gall as a director | 28,371,018 | 100% | - | - | 1,432 |
9 | To re-elect Debra Leeves as a director | 24,074,907 | 100% | - | - | 4,297,543 |
10 | To re-elect Nick Rodgers as a director | 28,371,018 | 100% | - | - | 1,432 |
11 | To elect Jon Kempster as a director | 28,371,018 | 100% | - | - | 1,432 |
12 | Authority to allot shares | 28,340,996 | 99.89% | 30,446 | 0.11% | 1,008 |
13 | Authority to disapply pre-emption rights2 | 28,323,483 | 99.83% | 47,959 | 0.17% | 1,008 |
14 | Authority to purchase own shares on the market2 | 24,925,895 | 99.84% | 39,143 | 0.16% | 3,407,412 |
Notes
1. Indicates an advisory vote.
2. Indicates a Special Resolution requiring 75% of votes cast to be carried.
Enquiries:
Cambridge Cognition Holdings plc |
Tel: 012 2381 0700 |
Rob Baker, Joint Managing Director and Chief Operating Officer |
|
| |
Panmure Liberum Limited (NOMAD and Joint Broker) | Tel: 020 7886 2968 |
Freddy Crossley / Will Goode / Mark Rogers | (Corporate Finance) |
Rupert Dearden | (Corporate Broking)
|
| |
Dowgate Capital Limited (Joint Broker) | Tel: 020 3903 7715 |
David Poutney / Amber Higgs | |
Hudson Sandler (Financial PR and IR) Dan de Belder / Hattie Dreyfus / Jackson Redley
| Tel: 020 7796 4133 |
Notes to Editors
About Cambridge Cognition
Cambridge Cognition is a brain health software group specialising in digital health products that advance brain health research and treatment.
Built on rich, curated data and deep technical expertise we are building a strong global brand with scalable technology that will support the rising world demand for diagnosing and treating brain health. The Company creates shareholder value through organic sales growth, strategic partnerships, joint ventures, and spinouts. The Company has identified four market sectors:
· Clinical Studies for new pharmaceuticals;
· Academic Research for scientists to understand CNS disorders;
· Healthcare to provide physicians with cognitive assessments to allow them to diagnose and treat patients; and,
· Consumer Health & Wellness to provide individuals access to accurate, reliable, and meaningful data to assess their cognitive health.
For further information, visit: www.cambridgecognition.com/
Related Shares:
Cambridge Cog